Plain-English translation of NCT07675161 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing the MiniMed Fit Payload adhesive components — the sticky backing used to attach a new patch-style insulin pump to the skin. Researchers want to understand how well these adhesives work in different locations on the body over a week-long period. The goal is to make sure the patch pump will be safe, comfortable, and effective for young people with diabetes.
Currently available insulin pumps don't offer the convenience and flexibility that many young patients need. This trial is helping develop a newer, smaller patch-pump design that could be easier and less noticeable to wear, while still delivering insulin reliably.
You likely qualify if…
You likely don't qualify if…
You would wear the adhesive patch in different locations on your body over a 7-day period. This helps researchers understand which placement works best and how well the adhesive holds up. The study involves visiting the research site, having the patch applied by staff, and reporting any skin reactions or comfort issues during the week.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States
Sponsor
Medtronic MiniMed, Inc.
Enrollment target
~100 participants
Started
June 2026
Primary completion
August 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
7 Years – 17 Years
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
McKenna Cherry
Medtronic MiniMed, Inc.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.